Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-033633
Filing Date
2022-06-02
Accepted
2022-06-02 17:14:48
Documents
1
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4269
  Complete submission text file 0001209191-22-033633.txt   5761
Mailing Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502
Business Address 1124 W CARSON STREET MRL BUILDING 3-320 TORRANCE CA 90502 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRYOR CASHMAN LLP 7 TIMES SQUARE NEW YORK NY 10036
Business Address
Williams Donald Allen (Reporting) CIK: 0001620013 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 22991943